Megan Boston - Mar 6, 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Executive Director, Director
Signature
/s/ Megan Boston
Stock symbol
BNTC
Transactions as of
Mar 6, 2024
Transactions value $
$0
Form type
4
Date filed
3/8/2024, 04:12 PM
Previous filing
Aug 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +200K $0.00 200K Mar 6, 2024 Common Stock 200K $5.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027.